QUIT

Achieve Life Sciences, Inc.

Healthcare
Medical - Pharmaceuticals
$659M market cap

Forecast run · Nov 12, 2026Upside rank 810 of 3,194

Model Signal

ForecastQ Daily Probabilities

39.8%

36.0%

33.0%

Analyst Consensus

Recommendation2.00/5 Buy

Last price$6.40

Price target$15.25

Implied move+138.3%

Analysts6

ForecastQ Portfolios

QUIT is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.